Search Results - "Dave, Shruti"

Refine Results
  1. 1

    Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow–derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus by Thakkar, Umang G, Trivedi, Hargovind L, Vanikar, Aruna V, Dave, Shruti D

    Published in Cytotherapy (Oxford, England) (01-07-2015)
    “…Abstract Background aims Stem cell therapy (SCT) is now the up-coming therapeutic modality for treatment of type 1 diabetes mellitus (T1DM). Methods Our study…”
    Get full text
    Journal Article
  2. 2

    Extrinsic factors promoting insulin producing cell-differentiation and insulin expression enhancement-hope for diabetics by Dave, Shruti

    Published in Current stem cell research & therapy (01-11-2013)
    “…Diabetes mellitus (DM) is considered to be an autoimmune disorder leading to destruction of beta-cells resulting in to a loss of blood sugar control. Attempts…”
    Get more information
    Journal Article
  3. 3

    Fish oil-containing multicomponent lipid emulsion vs soy-based lipid emulsion and neurodevelopmental outcomes of children born < 29 weeks’ gestation by Torgalkar, Ranjit, Shah, Jyotsna, Dave, Shruti, Yang, Junmin, Ostad, Nastaran, Kotsopoulos, Kirsten, Unger, Sharon, Kelly, Edmond, Shah, Prakesh S.

    Published in Journal of perinatology (01-11-2020)
    “…Objective To compare neurodevelopmental outcomes of extremely preterm children who received soy-medium chain triglycerides-olive-fish oil-containing lipid…”
    Get full text
    Journal Article
  4. 4

    Abrogation of Anti-HLA Antibodies via Proteasome Inhibition by TRIVEDI, Hargovind L, TERASAKI, Paul I, KHEMCHANDANI, Sajani I, DAVE, Shruti D, FEROZ, Aziz, EVERLY, Matthew J, VANIKAR, Aruna V, SHANKAR, Vangipurapu, TRIVEDI, Varsha B, KANEKU, Hugo, IDICA, Adam K, MODI, Pranjal R

    Published in Transplantation (27-05-2009)
    “…Current treatments for autoantibody-mediated diseases (i.e., systemic lupus erythematosus) and alloantibodies (in transplant) are minimally effective. Although…”
    Get full text
    Journal Article
  5. 5

    In vitro differentiation of neural cells from human adipose tissue derived stromal cells by Dave, Shruti, Patel, Chetan, Vanikar, Aruna, Trivedi, Hargovind

    Published in Neurology India (01-05-2018)
    “…Background: Stem cells, including neural stem cells (NSCs), are endowed with self-renewal capability and hence hold great opportunity for the institution of…”
    Get full text
    Journal Article
  6. 6

    Mesenchymal stem cells derived in vitro transdifferentiated insulin-producing cells: A new approach to treat type 1 diabetes by Dave, Shruti

    Published in Advanced biomedical research (2014)
    “…The pathophysiology of type 1 diabetes mellitus (T1DM) is largely related to an innate defect in the immune system culminating in a loss of self-tolerance and…”
    Get full text
    Journal Article
  7. 7

    In vitro Generated Mesenchymal Stem Cells: Suitable Tools to Target Insulin Dependent Diabetes Mellitus? by Dave, Shruti D, Patel, Chetan N, Patel, Jignesh V, Thakkar, Umang G

    Published in Current stem cell research & therapy (01-05-2017)
    “…A synergy of a pre-accumulated genes with an autoimmunity advancing to slow abolition of pancreatic beta-cells causes insulin deficiency and results enrooting…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10

    In-vitro generation of human adipose tissue derived insulin secreting cells: up-regulation of Pax-6, Ipf-1 and Isl-1 by Dave, Shruti D., Vanikar, Aruna V., Trivedi, Hargovind L.

    Published in Cytotechnology (Dordrecht) (01-03-2014)
    “…We present a study of up-regulation of genes responsible for pancreatic development in glucose-sensitive insulin-secreting mesenchymal stem cells (IS-MSC)…”
    Get full text
    Journal Article
  11. 11

    Stimulation of distinct parietal locations differentiates frontal versus hippocampal network involvement in memory formation by Dave, Shruti, VanHaerents, Stephen, Bonakdarpour, Borna, Mesulam, M.- Marsel, Voss, Joel L.

    Published in Current research in neurobiology (01-01-2022)
    “…Adjacent regions of parietal cortex are thought to affiliate with distinct large-scale networks and thereby make different contributions to memory formation…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Pre-transplant co-infusion of donor-adipose tissue derived mesenchymal stem cells and hematopoietic stem cells may help in achieving tolerance in living donor renal transplantation by Vanikar, Aruna V, Trivedi, Hargovind L, Gopal, Saroj Chooramani, Kumar, Ashutosh, Dave, Shruti D

    Published in Renal failure (01-04-2014)
    “…Transplantation tolerance is still a Utopian dream for many transplanters. Mesenchymal stem cells (MSC) have shown immuno-modulatory and tolerogenic effects in…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Stem cells versus donor specific transfusions for tolerance induction in living donor renal transplantation: a single-center experience by Dave, Shruti D, Vanikar, Aruna, Trivedi, Hargovind L, Gumber, Manoj R, Patel, Himanshu V, Shah, Pankaj R, Kute, Vivek B

    Published in Transplantation (15-01-2013)
    “…We undertook this study to define the role of stem cell transplantation (SCT) versus donor-specific transfusion (DST) in tolerance induction and sustenance in…”
    Get full text
    Journal Article
  16. 16

    Combined therapy of insulin-producing cells and haematopoietic stem cells offers better diabetic control than only haematopoietic stem cells’ infusion for patients with insulin-dependent diabetes by Dave, Shruti D, Trivedi, Hargovind L, Gopal, Saroj C, Chandra, Tulika

    Published in BMJ case reports (08-09-2014)
    “…Insulin-dependent diabetes mellitus (IDDM) is a chronic condition characterised by impaired blood sugar metabolism and autoimmunity. We report two children: a…”
    Get full text
    Journal Article
  17. 17

    Management of type 1 diabetes mellitus using in vitro autologous adipose tissue trans-differentiated insulin-making cells by Dave, Shruti D, Trivedi, Hargovind L, Chooramani, Saroj G, Chandra, Tulika

    Published in BMJ case reports (26-07-2013)
    “…Type 1 diabetes mellitus (T1DM) is a result of autoimmune destruction of insulin-producing β cells of pancreas. Insulin is a widely used therapeutic modality…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Co-infusion of adipose tissue derived mesenchymal stem cell-differentiated insulin-making cells and haematopoietic cells with renal transplantation: a novel therapy for type 1 diabetes mellitus with end-stage renal disease by Dave, Shruti D, Vanikar, Aruna V, Trivedi, Hargovind L

    Published in BMJ case reports (23-05-2013)
    “…Type 1 diabetes mellitus (T1DM) is a common cause of end-stage renal disease (ESRD). Various factors contribute to wide fluctuations in blood glucose levels…”
    Get full text
    Journal Article